600085.SS
Beijing Tongrentang Co., Ltd
ShanghaiCNYEQUITY
Healthcare
DELAYED
Last price
23.78
▼ 0.66 (2.70%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
24.34
Prev close
24.44
Day high
24.35
Day low
23.71
Volume
7.75M
Market cap
$32.60B
P/E (TTM)
30.09
52W range
21.87 – 37.48
Day trading desk
Gap from prior close
-0.41%
Prior close 24.44
VWAP
23.86
-0.35% from price
Relative volume
0.71×
Normal
Session range
2.61%
23.72 – 24.34
Position in range
10%
Near session low
ATR (14D)
0.52
2.18% of price
Prior day high
24.55
PDH
Prior day low
24.12
PDL
Bid / ask spread
—
Quote not published
Session volume
7.48M
Avg 10.52M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.90%
-1.5%
1M
-7.94%
-11.7%
3M
-5.86%
-9.0%
6M
-23.57%
-34.6%
YTD
-26.32%
-38.6%
1Y
-34.89%
-54.9%
3Y
-54.61%
-128.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 600085.SS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
728.18M
Total on file
Fundamentals
Market cap$32.60B
Enterprise value$32.43B
Revenue (TTM)$16.64B
Gross profit$6.83B
EBITDA$2.03B
Net income$1.08B
EPS (TTM)$0.79
Free cash flow$2.18B
Total cash$11.52B
Total debt$3.53B
Book value / share$10.27
Shares outstanding1.37B
Float652.16M
Short % of float—
Dividend yield2.10%
Beta (5Y)0.05
Valuation & profitability ratios
Trailing P/E30.09
Forward P/E21.81
PEG ratio—
Price / sales—
Price / book2.31
EV / revenue1.95
EV / EBITDA15.99
Gross margin41.04%
Operating margin15.22%
Profit margin6.48%
Return on equity6.45%
Return on assets3.28%
Debt / equity16.12
Current ratio3.77
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $17.26B | $18.60B | $17.86B | $15.37B | -7.2% |
| Operating revenue | $17.26B | $18.60B | $17.86B | $15.37B | -7.2% |
| Cost of revenue | $9.86B | $10.42B | $9.41B | $7.87B | -5.4% |
| Gross profit | $7.40B | $8.18B | $8.45B | $7.50B | -9.5% |
| Research & development | $291.98M | $269.40M | $279.82M | $217.45M | +8.4% |
| Selling, general & admin | $1.61B | $1.76B | $1.56B | $1.46B | -8.1% |
| Total operating expense | $5.31B | $5.39B | $5.35B | $4.71B | -1.5% |
| Operating income | $2.09B | $2.79B | $3.10B | $2.80B | -25.1% |
| Net interest income | $61.49M | -$2.33M | $106.13M | -$210.29K | +2,744.4% |
| Pre-tax income | $2.03B | $2.81B | $3.08B | $2.72B | -27.8% |
| Tax provision | $393.51M | $525.05M | $497.43M | $512.86M | -25.1% |
| Net income | $1.19B | $1.53B | $1.67B | $1.43B | -22.1% |
| Net income to common | $1.19B | $1.53B | $1.67B | $1.43B | -22.1% |
| Basic EPS | 0.87 | 1.11 | 1.22 | 1.04 | -22.1% |
| Diluted EPS | 0.87 | 1.11 | 1.22 | 1.04 | -22.1% |
| EBIT | $2.15B | $2.94B | $3.18B | $2.83B | -26.8% |
| EBITDA | $3.20B | $3.91B | $4.10B | $3.71B | -18.1% |
| Basic shares | 1.37B | 1.37B | 1.37B | 1.37B | +0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $10.88B | $10.76B | $12.13B | $11.62B | +1.1% |
| Cash & short-term investments | $11.00B | $10.76B | $12.13B | $11.62B | +2.2% |
| Accounts receivable | $1.00B | $1.32B | $1.06B | $1.30B | -24.3% |
| Inventory | $10.62B | $10.73B | $9.34B | $6.69B | -1.1% |
| Total current assets | $23.40B | $23.70B | $23.36B | $20.56B | -1.2% |
| Property, plant & equipment | $5.65B | $5.97B | $5.48B | $5.29B | -5.4% |
| Goodwill & intangibles | $821.74M | $829.35M | $800.61M | $791.61M | -0.9% |
| Total assets | $30.62B | $31.20B | $30.09B | $27.05B | -1.8% |
| Total current liabilities | $6.52B | $7.60B | $7.16B | $6.34B | -14.2% |
| Current debt | $115.06M | $187.72M | $93.02M | $309.53M | -38.7% |
| Long-term debt | $1.46B | $1.25B | $1.43B | $1.22B | +17.2% |
| Total debt | $3.61B | $4.30B | $3.11B | $2.88B | -16.1% |
| Total liabilities | $9.24B | $10.30B | $9.83B | $8.59B | -10.2% |
| Retained earnings | $8.78B | $8.39B | $8.37B | $7.27B | +4.7% |
| Shareholder equity | $13.66B | $13.20B | $13.06B | $11.81B | +3.5% |
| Working capital | $16.88B | $16.10B | $16.20B | $14.22B | +4.9% |
| Net tangible assets | $12.83B | $12.37B | $12.26B | $11.02B | +3.8% |
| Shares issued | 1.37B | 1.37B | 1.37B | 1.37B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.63B | $2.28B | $2.58B | $2.20B | -28.4% |
| Depreciation & amortisation | $1.05B | $971.46M | $915.27M | $885.59M | +8.2% |
| Change in working capital | -$308.08M | -$2.54B | -$1.68B | -$127.64M | +87.9% |
| Operating cash flow | $2.69B | $760.99M | $1.87B | $3.09B | +253.9% |
| Capital expenditure | -$357.30M | -$519.55M | -$324.51M | -$330.03M | +31.2% |
| Investing cash flow | -$217.35M | -$662.12M | -$76.18M | -$211.39M | +67.2% |
| Dividends paid | -$695.07M | -$1.37B | -$483.09M | -$442.42M | +49.4% |
| Financing cash flow | -$2.26B | -$1.61B | -$1.43B | -$1.31B | -40.5% |
| Free cash flow | $2.34B | $241.43M | $1.54B | $2.76B | +867.4% |
| End cash position | $10.72B | $10.54B | $12.02B | $11.62B | +1.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $4.66B | $3.95B | $4.49B | $5.28B | $4.78B | +18.1% |
| Operating revenue | $4.66B | $3.95B | $4.49B | $5.28B | $4.78B | +18.1% |
| Cost of revenue | $2.72B | $2.39B | $2.57B | $2.87B | $2.64B | +14.0% |
| Gross profit | $1.94B | $1.56B | $1.93B | $2.40B | $2.14B | +24.4% |
| Research & development | $51.64M | $149.05M | $54.30M | $36.47M | $130.31M | -65.4% |
| Selling, general & admin | $1.13B | -$2.02B | -$530.53M | $1.39B | -$1.72B | +156.1% |
| Total operating expense | $1.22B | $1.48B | $1.24B | $1.45B | $1.76B | -17.5% |
| Operating income | $726.31M | $86.24M | $688.46M | $951.81M | $377.99M | +742.2% |
| Net interest income | $39.77M | $16.97M | -$14.65M | $47.27M | -$12.11M | +134.4% |
| Pre-tax income | $748.37M | $67.54M | $616.47M | $996.10M | $386.73M | +1,008.0% |
| Tax provision | $131.64M | $27.32M | $122.20M | $155.20M | $90.05M | +381.9% |
| Net income | $471.18M | $11.82M | $363.29M | $582.21M | $176.22M | +3,886.8% |
| Net income to common | $471.18M | $11.82M | $363.29M | $582.21M | $176.22M | +3,886.8% |
| Basic EPS | 0.34 | — | — | 0.43 | — | — |
| Diluted EPS | 0.34 | — | — | 0.43 | — | — |
| EBIT | $774.45M | $95.73M | $648.16M | $1.03B | $422.95M | +709.0% |
| EBITDA | $774.45M | $95.73M | $648.16M | $1.03B | $422.95M | +709.0% |
| Basic shares | 1.37B | — | — | 1.37B | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.66B | $10.88B | $11.25B | $11.38B | $10.76B | -2.0% |
| Cash & short-term investments | $11.52B | $11.00B | $11.35B | $11.38B | $10.76B | +4.7% |
| Accounts receivable | $1.89B | $1.00B | $1.47B | $1.77B | $1.32B | +88.8% |
| Inventory | $9.62B | $10.62B | $10.89B | $10.87B | $10.73B | -9.4% |
| Total current assets | $23.83B | $23.40B | $24.52B | $24.88B | $23.70B | +1.8% |
| Property, plant & equipment | $5.63B | $5.65B | $5.85B | $5.87B | $5.97B | -0.4% |
| Goodwill & intangibles | $812.39M | $821.74M | $817.48M | $824.38M | $829.35M | -1.1% |
| Total assets | $31.01B | $30.62B | $31.95B | $32.31B | $31.20B | +1.3% |
| Total current liabilities | $6.32B | $6.52B | $7.43B | $7.21B | $7.60B | -3.0% |
| Current debt | $129.01M | $115.06M | $119.00M | $121.04M | $187.72M | +12.1% |
| Long-term debt | $1.41B | $1.46B | $1.89B | $1.89B | $1.25B | -3.5% |
| Total debt | $3.53B | $3.61B | $4.18B | $4.19B | $4.30B | -2.2% |
| Total liabilities | $9.10B | $9.24B | $10.77B | $10.55B | $10.30B | -1.6% |
| Retained earnings | $9.25B | $8.78B | $8.65B | $8.97B | $8.39B | +5.4% |
| Shareholder equity | $14.09B | $13.66B | $13.43B | $13.77B | $13.20B | +3.1% |
| Working capital | $17.50B | $16.88B | $17.08B | $17.67B | $16.10B | +3.7% |
| Net tangible assets | $13.27B | $12.83B | $12.61B | $12.95B | $12.37B | +3.4% |
| Shares issued | 1.37B | 1.37B | 1.37B | 1.37B | 1.37B | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$50.77M | -$111.24M | -$69.02M | -$74.50M | -$205.53M | +54.4% |
| Investing cash flow | -$777.55M | $185.06M | -$234.79M | -$48.26M | -$438.70M | -520.1% |
| Dividends paid | -$43.58M | $42.39M | -$701.75M | -$16.73M | -$664.16M | -202.8% |
| Financing cash flow | -$321.74M | -$693.34M | -$1.13B | -$192.12M | -$763.59M | +53.6% |
| Free cash flow | $891.73M | $593.77M | $1.05B | $758.08M | $608.01M | +50.2% |
| End cash position | $10.52B | $10.72B | $10.86B | $11.12B | $10.54B | -1.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2026 | — | 0.34 | — |
| Dec 2025 | 0.31 | 0.01 | -96.8% |
| Sep 2025 | 0.24 | 0.17 | -29.2% |
| Jun 2025 | 0.36 | 0.26 | -26.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.28 | 1 | $0 | — |
| Next quarter | 0.22 | 1 | $0 | — |
| Current year | 0.96 | 1 | $18.42B | +6.8% |
| Next year | 1.09 | 2 | $19.46B | +5.6% |
Analyst targets & ownership
Mean target$35.55
High target$45.54
Low target$24.00
Implied upside49.50%
Analyst count5
ConsensusNONE
Strong buy / Buy0 / 4
Hold0
Sell / Strong sell1 / 0
Held by insiders53.10%
Held by institutions5.25%
Institutions holding156
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
24.51
-2.98% from price
SMA 20
25.07
-5.17% from price
SMA 50
24.57
-3.26% from price
SMA 100
25.70
-7.46% from price
SMA 200
28.79
-17.43% from price
EMA 12
24.55
-3.12% from price
EMA 26
24.81
-4.14% from price
EMA 50
25.04
-5.02% from price
RSI (14)
37.1
Neutral
MACD (12,26,9)
-0.26
Hist -0.17
ATR (14)
0.52
2.18% of price
Realised vol 30D
31.4%
Annualised
Bollinger upper
26.51
20, 2σ
Bollinger lower
23.62
20, 2σ
50 / 200 cross
Death
24.57 vs 28.79
Trend bias
Below 200
-17.43%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.04
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
31.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-40.1%
Peak to trough
Max drawdown 5Y
-64.3%
Peak to trough
ATR 14
0.52
2.18% of price
Beta (reported)
0.05
5Y monthly, from filing
Dividends & splits
Forward rate$0.50 / yr
Forward yield2.10%
5-year avg yield1.30%
Payout ratio63.61%
Ex-dividend dateJul 1, 2026
Next pay date—
Last split25:10
Split dateJul 12, 2011
Headlines
Puzzle solutions for Sunday, Aug. 23, 2026
USA TODAY · 11m ago
Prenups cover more than just marriage and divorce these days
USA TODAY · 13m ago
The $4.2 Million Couple Left New York to Save on Roth Conversions. One Medicare Bill Followed Them to Florida.
24/7 Wall St. · 14m ago
Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?
Motley Fool · 14m ago
Social Security's future is shaky. Trump prefers this country's system
USA TODAY · 16m ago
Sell U.S. dollar versus these currencies, BCA says
Investing.com · 18m ago
Arts Calendar: Happenings for the Week of August 23
The Wall Street Journal · 18m ago
Why Democrats Still Have a Shot at Winning the Senate
The Wall Street Journal · 18m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.